MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$1,070K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income/(loss)
Issuance of shares, options exer...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Accounts receivable
Cash paid for taxes on restricte...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net income/(loss)
1,973
5,155
-637
-4,317
Inventory reserve
-
-
-517
-
Allowance for credit losses
-287
-120
-1,155
1,222
Amortization of debt discount
-
-
12
26
Loss on securities
-
-
0
2
Amortization of norgine asset
25
-51
26
51
Stock-based compensation
1,774
-3,521
2,219
2,292
Accounts receivable
4,217
-13,494
3,440
5,542
Prepaid expenses
174
1,404
-3,340
1,659
Other assets
-
-
-520
435
Inventory
518
-1,126
276
1,141
Other current assets
-646
891
-
-
Other non-current assets
-1,664
1,460
-
-
Accounts payable
-765
-979
-75
2,700
Accrued liabilities
639
-2,851
1,476
-1,203
Contract liability
-710
-
-
-
Net cash provided by/(used in) operating activities
50
8,890
1,493
-8,004
Issuance of shares, options exercise
1,961
-662
1,799
186
Cash paid for taxes on restricted share release
941
150
50
111
Net cash provided by financing activities
1,020
-812
1,749
75
Increase/(decrease) in cash and cash equivalents
1,070
8,078
3,242
-7,929
Cash and cash equivalents - beginning of year
21,947
21,947
26,634
-
Cash and cash equivalents - end of year
41,249
40,179
21,947
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Issuance of shares,
options exercise
$1,961K
(954.30%↑ Y/Y)
Net income/(loss)
$1,973K
(145.70%↑ Y/Y)
Stock-based compensation
$1,774K
(-22.60%↓ Y/Y)
Other non-current
assets
-$1,664K
Other current assets
-$646K
Accrued liabilities
$639K
(153.12%↑ Y/Y)
Amortization of norgine asset
$25K
(-50.98%↓ Y/Y)
Net cash provided by
financing activities
$1,020K
(1260.00%↑ Y/Y)
Net cash provided
by/(used in) operating...
$50K
(100.62%↑ Y/Y)
Canceled cashflow
$941K
Canceled cashflow
$6,671K
Increase/(decrease) in cash and cash
equivalents
$1,070K
(113.49%↑ Y/Y)
Cash paid for taxes on
restricted share release
$941K
(747.75%↑ Y/Y)
Accounts receivable
$4,217K
(-23.91%↓ Y/Y)
Accounts payable
-$765K
(-128.33%↓ Y/Y)
Contract liability
-$710K
Inventory
$518K
(-54.60%↓ Y/Y)
Allowance for credit
losses
-$287K
(-123.49%↓ Y/Y)
Prepaid expenses
$174K
(-89.51%↓ Y/Y)
Buy us a coffee
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)